Raras
Buscar doenças, sintomas, genes...
Eritroceratodermia
ORPHA:79355DOENÇA RARA

É um termo genérico para um grupo de doenças de pele genéticas raras, caracterizadas por placas bem delimitadas de pele avermelhada, seca e espessa. Geralmente, essas lesões se distribuem de forma simétrica no corpo e tendem a aumentar lentamente de tamanho e a evoluir com o tempo.

Mantido por Agente Raras·Colaborar como especialista →

Introdução

O que você precisa saber de cara

📋

É um termo genérico para um grupo de doenças de pele genéticas raras, caracterizadas por placas bem delimitadas de pele avermelhada, seca e espessa. Geralmente, essas lesões se distribuem de forma simétrica no corpo e tendem a aumentar lentamente de tamanho e a evoluir com o tempo.

Publicações científicas
173 artigos
Último publicado: 2026 Mar 19
Medicamentos
5 registrados
IXEKIZUMAB, GUSELKUMAB, CRAVACITINIB

Tem tratamento?

5 medicamentos registrados
Ver detalhes, fases e interações →
IXEKIZUMABGUSELKUMABCRAVACITINIBDEUCRAVACITINIBSECUKINUMAB
🏥
SUS: Sem cobertura SUSScore: 0%
Você se identifica com essa condição?
O Raras está aqui pra te apoiar — com ou sem diagnóstico

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Entender a doença

Do básico ao detalhe, leia no seu ritmo

Preparando trilha educativa...

Sinais e sintomas

O que aparece no corpo e com que frequência cada sintoma acontece

Partes do corpo afetadas

🧬
Pele e cabelo
32 sintomas
🧠
Neurológico
15 sintomas
🫃
Digestivo
7 sintomas
💪
Músculos
5 sintomas
👁️
Olhos
5 sintomas
❤️
Coração
5 sintomas

+ 46 sintomas em outras categorias

Características mais comuns

Rigidez articular
Braquidactilia
Baixa estatura
Diabetes mellitus
Perda de peso
Deficiência auditiva
132sintomas
Sem dados (132)

Os sintomas variam de pessoa para pessoa. Abaixo estão as 132 características clínicas mais associadas, ordenadas por frequência.

Rigidez articularJoint stiffness
BraquidactiliaBrachydactyly
Baixa estaturaShort stature
Diabetes mellitus
Perda de pesoWeight loss

Linha do tempo da pesquisa

Publicações por ano — veja quando o interesse científico cresceu
Anos de pesquisa1desde 2026
Total histórico173PubMed
Últimos 10 anos52publicações
Pico20258 papers
Linha do tempo
2026Hoje · 2026📈 2025Ano de pico
Publicações por ano (últimos 10 anos)

Encontrou um erro ou informação desatualizada? Sugira uma correção →

Genética e causas

O que está alterado no DNA e como passa nas famílias

Genes associados

13 genes identificados com associação a esta condição.

CARD14Caspase recruitment domain-containing protein 14Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Acts as a scaffolding protein that can activate the inflammatory transcription factor NF-kappa-B and p38/JNK MAP kinase signaling pathways. Forms a signaling complex with BCL10 and MALT1, and activates MALT1 proteolytic activity and inflammatory gene expression. MALT1 is indispensable for CARD14-induced activation of NF-kappa-B and p38/JNK MAP kinases (PubMed:11278692, PubMed:21302310, PubMed:27071417, PubMed:27113748). May play a role in signaling mediated by TRAF2, TRAF3 and TRAF6 and protects

LOCALIZAÇÃO

Cytoplasm

MECANISMO DE DOENÇA

Psoriasis 2

A common, chronic inflammatory disease of the skin with multifactorial etiology. It is characterized by red, scaly plaques usually found on the scalp, elbows and knees. These lesions are caused by abnormal keratinocyte proliferation and infiltration of inflammatory cells into the dermis and epidermis.

OUTRAS DOENÇAS (2)
familial pityriasis rubra pilarispsoriasis 2
HGNC:16446UniProt:Q9BXL6
LORICRINLoricrinCandidate gene tested inTolerante
FUNÇÃO

Major keratinocyte cell envelope protein

LOCALIZAÇÃO

CytoplasmNucleus, nucleoplasm

VIAS BIOLÓGICAS (2)
Formation of the cornified envelopeDifferentiation of Keratinocytes in Interfollicular Epidermis in Mammalian Skin
MECANISMO DE DOENÇA

Vohwinkel syndrome with ichthyosis

A variant form of Vohwinkel syndrome without hearing loss and associated with ichthyosiform dermatosis. Clinical features include palmoplantar keratoderma, pseudoainhum and ichthyosis. Compact hyperkeratosis with round retained nuclei and hypergranulosis is observed on skin biopsies.

OUTRAS DOENÇAS (2)
loricrin keratodermaerythrokeratodermia variabilis
HGNC:6663UniProt:P23490
AP1B1AP-1 complex subunit beta-1Candidate gene tested inAltamente restrito
FUNÇÃO

Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes (PubMed:31630791). The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules

LOCALIZAÇÃO

Golgi apparatusCytoplasmic vesicle, clathrin-coated vesicle membrane

VIAS BIOLÓGICAS (2)
MHC class II antigen presentationLysosome Vesicle Biogenesis
MECANISMO DE DOENÇA

Keratitis-ichthyosis-deafness syndrome, autosomal recessive

An autosomal recessive form of keratitis-ichthyosis-deafness syndrome, a disease characterized by the association of hyperkeratotic skin lesions with vascularizing keratitis and profound sensorineural hearing loss. KIDAR patients manifest ichthyosis, failure to thrive and developmental delay in childhood, thrombocytopenia, photophobia, and progressive hearing loss. Low plasma copper and ceruloplasmin levels have been reported in some patients.

OUTRAS DOENÇAS (2)
ichthyosiform erythroderma, corneal involvement, and hearing lossMEDNIK syndrome
HGNC:554UniProt:Q10567
GJB4Gap junction beta-4 proteinDisease-causing germline mutation(s) inDesconhecido
FUNÇÃO

Structural component of gap junctions (By similarity). Gap junctions are dodecameric channels that connect the cytoplasm of adjoining cells. They are formed by the docking of two hexameric hemichannels, one from each cell membrane (By similarity). Small molecules and ions diffuse from one cell to a neighboring cell via the central pore (By similarity)

LOCALIZAÇÃO

Cell membraneCell junction, gap junction

VIAS BIOLÓGICAS (1)
Gap junction assembly
MECANISMO DE DOENÇA

Erythrokeratodermia variabilis et progressiva 2

A form of erythrokeratodermia variabilis et progressiva, a genodermatosis characterized by the coexistence of two independent skin lesions: transient erythema and hyperkeratosis that is usually localized but occasionally occurs in its generalized form. Clinical presentation varies significantly within a family and from one family to another. Palmoplantar keratoderma is present in around 50% of cases.

VIAS REACTOME (1)
EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Not Sun Exposed Suprapubic
44.3 TPM
Skin Sun Exposed Lower leg
43.6 TPM
Esôfago - Mucosa
2.4 TPM
Vagina
2.1 TPM
Próstata
0.9 TPM
OUTRAS DOENÇAS (2)
erythrokeratodermia variabilis et progressiva 2erythrokeratodermia variabilis
HGNC:4286UniProt:Q9NTQ9
KRT83Keratin, type II cuticular Hb3Disease-causing germline mutation(s) inTolerante
LOCALIZAÇÃO

VIAS BIOLÓGICAS (2)
KeratinizationFormation of the cornified envelope
MECANISMO DE DOENÇA

Erythrokeratodermia variabilis et progressiva 5

A form of erythrokeratodermia variabilis et progressiva, a genodermatosis characterized by the coexistence of two independent skin lesions: transient erythema and hyperkeratosis that is usually localized but occasionally occurs in its generalized form. Clinical presentation varies significantly within a family and from one family to another. Palmoplantar keratoderma is present in around 50% of cases. EKVP5 inheritance is autosomal recessive.

EXPRESSÃO TECIDUAL(Baixa expressão)
Brain Spinal cord cervical c-1
1.8 TPM
Tireoide
1.5 TPM
Córtex cerebral
0.7 TPM
Brain Frontal Cortex BA9
0.6 TPM
Substância negra
0.6 TPM
INTERAÇÕES PROTEICAS (2)
OUTRAS DOENÇAS (4)
monilethrix-3erythrokeratodermia variabilis et progressiva 5monilethrixerythrokeratodermia variabilis
HGNC:6460UniProt:P78385
GJB3Gap junction beta-3 proteinDisease-causing germline mutation(s) inTolerante
FUNÇÃO

One gap junction consists of a cluster of closely packed pairs of transmembrane channels, the connexons, through which materials of low MW diffuse from one cell to a neighboring cell

LOCALIZAÇÃO

Cell membraneCell junction, gap junction

VIAS BIOLÓGICAS (1)
Gap junction assembly
MECANISMO DE DOENÇA

Erythrokeratodermia variabilis et progressiva 1

A form of erythrokeratodermia variabilis et progressiva, a genodermatosis characterized by the coexistence of two independent skin lesions: transient erythema and hyperkeratosis that is usually localized but occasionally occurs in its generalized form. Clinical presentation varies significantly within a family and from one family to another. Palmoplantar keratoderma is present in around 50% of cases.

EXPRESSÃO TECIDUAL(Tecido-específico)
Skin Sun Exposed Lower leg
184.0 TPM
Skin Not Sun Exposed Suprapubic
182.9 TPM
Esôfago - Mucosa
87.3 TPM
Vagina
41.6 TPM
Próstata
4.5 TPM
INTERAÇÕES PROTEICAS (5)
OUTRAS DOENÇAS (7)
autosomal dominant nonsyndromic hearing loss 2Bautosomal recessive nonsyndromic hearing loss 1Aerythrokeratodermia variabilis et progressiva 1hearing loss, autosomal recessive
HGNC:4285UniProt:O75712
DSPDesmoplakinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

A component of desmosome cell-cell junctions which are required for positive regulation of cellular adhesion (PubMed:25733715). Critical for cell-cell adhesion in early stage blastocysts and progression through proamniotic cavity formation (By similarity). Not required for preimplantation morphogenic process in blastocysts (By similarity). Required for keratin filament anchoring at the desmosome junction and subsequent organization of the keratin intermediate filament network within the cytoplas

LOCALIZAÇÃO

Cell projection, axonCell junction, desmosomeCell membraneCytoplasmNucleus

VIAS BIOLÓGICAS (6)
Apoptotic cleavage of cell adhesion proteinsNeutrophil degranulationKeratinizationFormation of the cornified envelopeRND1 GTPase cycle
MECANISMO DE DOENÇA

Keratoderma, palmoplantar, striate 2

A dermatological disorder characterized by thickening of the skin on the palms (linear pattern) and the soles (island-like pattern) and flexor aspect of the fingers. Abnormalities of the nails, the teeth and the hair are rarely present.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
1294.4 TPM
Skin Not Sun Exposed Suprapubic
1155.3 TPM
Esôfago - Mucosa
647.4 TPM
Vagina
416.9 TPM
Glândula salivar
87.7 TPM
OUTRAS DOENÇAS (13)
arrhythmogenic cardiomyopathy with wooly hair and keratodermakeratosis palmoplantaris striata 2lethal acantholytic epidermolysis bullosacardiomyopathy, dilated, with wooly hair, keratoderma, and tooth agenesis
HGNC:3052UniProt:P15924
GJA1Gap junction alpha-1 proteinDisease-causing germline mutation(s) inAltamente restrito
FUNÇÃO

Structural component of the gap junction, a specialized intercellular structure consisting of a cluster of closely packed pairs of transmembrane channels, the connexons, that allow passage of small molecules and electrical signals between neighboring cells (By similarity). Forms homotypic and heterotypic channels gated by transjunctional voltage (By similarity). May play a critical role in the physiology of hearing by participating in the recycling of potassium to the cochlear endolymph (Probabl

LOCALIZAÇÃO

Cell membraneCell junction, gap junctionEndoplasmic reticulumCell junction

VIAS BIOLÓGICAS (4)
Regulation of gap junction activitySARS-CoV-2 targets PDZ proteins in cell-cell junctionGap junction assemblyMicrotubule-dependent trafficking of connexons from Golgi to the plasma membrane
MECANISMO DE DOENÇA

Oculodentodigital dysplasia

A disease characterized by a typical facial appearance and variable involvement of the eyes, dentition, and fingers. Characteristic facial features include a narrow, pinched nose with hypoplastic alae nasi, prominent columella and thin anteverted nares together with a narrow nasal bridge, and prominent epicanthic folds giving the impression of hypertelorism. The teeth are usually small and carious. Typical eye findings include microphthalmia and microcornea. The characteristic digital malformation is complete syndactyly of the fourth and fifth fingers (syndactyly type III) but the third finger may be involved and associated camptodactyly is a common finding. Cardiac abnormalities are observed in rare instances.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Not Sun Exposed Suprapubic
485.1 TPM
Glândula adrenal
439.8 TPM
Skin Sun Exposed Lower leg
408.1 TPM
Aorta
387.9 TPM
Cervix Endocervix
368.9 TPM
OUTRAS DOENÇAS (10)
oculodentodigital dysplasiaoculodentodigital dysplasia, autosomal recessiveautosomal dominant palmoplantar keratoderma and congenital alopeciacraniometaphyseal dysplasia, autosomal recessive
HGNC:4274UniProt:P17302
TRPM4Transient receptor potential cation channel subfamily M member 4Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Calcium-activated selective cation channel that mediates membrane depolarization (PubMed:12015988, PubMed:12842017, PubMed:29211723, PubMed:30528822). While it is activated by increase in intracellular Ca(2+), it is impermeable to it (PubMed:12015988). Mediates transport of monovalent cations (Na(+) > K(+) > Cs(+) > Li(+)), leading to depolarize the membrane (PubMed:12015988). It thereby plays a central role in cadiomyocytes, neurons from entorhinal cortex, dorsal root and vomeronasal neurons, e

LOCALIZAÇÃO

Cell membraneEndoplasmic reticulumGolgi apparatus

VIAS BIOLÓGICAS (2)
TRP channelsSensory perception of sweet, bitter, and umami (glutamate) taste
MECANISMO DE DOENÇA

Progressive familial heart block 1B

A cardiac bundle branch disorder characterized by progressive alteration of cardiac conduction through the His-Purkinje system, with a pattern of a right bundle-branch block and/or left anterior hemiblock occurring individually or together. It leads to complete atrio-ventricular block causing syncope and sudden death.

EXPRESSÃO TECIDUAL(Ubíquo)
Cólon transverso
69.4 TPM
Próstata
61.3 TPM
Skin Sun Exposed Lower leg
47.5 TPM
Glândula salivar
45.2 TPM
Skin Not Sun Exposed Suprapubic
41.8 TPM
OUTRAS DOENÇAS (5)
progressive familial heart block type IBerythrokeratodermia variabilis et progressiva 6Brugada syndromeprogressive familial heart block
HGNC:17993UniProt:Q8TD43
AP1S1AP-1 complex subunit sigma-1ADisease-causing germline mutation(s) inTolerante
FUNÇÃO

Subunit of clathrin-associated adaptor protein complex 1 that plays a role in protein sorting in the late-Golgi/trans-Golgi network (TGN) and/or endosomes. The AP complexes mediate both the recruitment of clathrin to membranes and the recognition of sorting signals within the cytosolic tails of transmembrane cargo molecules

LOCALIZAÇÃO

Golgi apparatusCytoplasmic vesicle membraneMembrane, clathrin-coated pit

VIAS BIOLÓGICAS (2)
MHC class II antigen presentationLysosome Vesicle Biogenesis
MECANISMO DE DOENÇA

MEDNIK syndrome

A disorder characterized by erythematous skin lesions and hyperkeratosis, severe psychomotor retardation, peripheral neuropathy, sensorineural hearing loss, together with elevated very-long-chain fatty acids and severe congenital diarrhea.

OUTRAS DOENÇAS (1)
MEDNIK syndrome
HGNC:559UniProt:P61966
ELOVL4Very long chain fatty acid elongase 4Disease-causing germline mutation(s) inModerado
FUNÇÃO

Catalyzes the first and rate-limiting reaction of the four reactions that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids (VLCFAs) per cycle. Condensing enzyme that catalyzes the synthesis of very long chain saturated (VLC-SFA) and polyunsaturated (PUFA) fatty acids that are involved in multiple biological processes as precursors of membrane lipids and

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Synthesis of very long-chain fatty acyl-CoAs
MECANISMO DE DOENÇA

Stargardt disease 3

A form of Stargardt disease, a common hereditary macular degeneration characterized by decreased central vision, atrophy of the macula and underlying retinal pigment epithelium, and frequent presence of prominent flecks in the posterior pole of the retina. STGD3 is an autosomal dominant form with onset most commonly in the second decade of life.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
68.2 TPM
Skin Not Sun Exposed Suprapubic
64.1 TPM
Cérebro - Hemisfério cerebelar
43.9 TPM
Cerebelo
27.9 TPM
Brain Frontal Cortex BA9
23.3 TPM
OUTRAS DOENÇAS (4)
spinocerebellar ataxia type 34Stargardt disease 3congenital ichthyosis-intellectual disability-spastic quadriplegia syndromeStargardt disease
HGNC:14415UniProt:Q9GZR5
PERPp53 apoptosis effector related to PMP-22Disease-causing germline mutation(s) inTolerante
FUNÇÃO

Component of intercellular desmosome junctions (By similarity). Plays a role in stratified epithelial integrity and cell-cell adhesion by promoting desmosome assembly (By similarity). Thereby plays a role in barrier function of the skin against infection (By similarity). Plays a role in mammary epithelial tissue homeostasis and remodeling during and after pregnancy, potentially via its involvement in desmosome cell-cell junctions (By similarity). Required for tooth enamel development via facilit

LOCALIZAÇÃO

Cell junction, desmosomeCell membraneCytoplasm

VIAS BIOLÓGICAS (2)
TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertainFormation of the cornified envelope
MECANISMO DE DOENÇA

Erythrokeratodermia variabilis et progressiva 7

A form of erythrokeratodermia variabilis et progressiva, a genodermatosis characterized by the coexistence of two independent skin lesions: transient erythema and hyperkeratosis that is usually localized but occasionally occurs in its generalized form. Clinical presentation varies significantly within a family and from one family to another. Palmoplantar keratoderma is present in around 50% of cases. EKVP7 is an autosomal recessive form characterized by palmoplantar keratoderma that extends to the dorsal surface of the hands and feet, as well as erythematous annular skin lesions. Pruritus, woolly hair, and dystrophic nails may also be present.

EXPRESSÃO TECIDUAL(Ubíquo)
Skin Sun Exposed Lower leg
2080.4 TPM
Skin Not Sun Exposed Suprapubic
1935.4 TPM
Esôfago - Mucosa
1234.2 TPM
Vagina
815.2 TPM
Glândula salivar
336.6 TPM
OUTRAS DOENÇAS (3)
Olmsted syndrome 2erythrokeratodermia variabilis et progressiva 7Olmsted syndrome
HGNC:17637UniProt:Q96FX8
KDSR3-ketodihydrosphingosine reductaseDisease-causing germline mutation(s) inTolerante
FUNÇÃO

Catalyzes the reduction of 3'-oxosphinganine (3-ketodihydrosphingosine/KDS) to sphinganine (dihydrosphingosine/DHS), the second step of de novo sphingolipid biosynthesis

LOCALIZAÇÃO

Endoplasmic reticulum membrane

VIAS BIOLÓGICAS (1)
Sphingolipid de novo biosynthesis
EXPRESSÃO TECIDUAL(Ubíquo)
Nervo tibial
48.9 TPM
Aorta
44.3 TPM
Skin Sun Exposed Lower leg
42.7 TPM
Brain Spinal cord cervical c-1
40.2 TPM
Artéria tibial
40.0 TPM
OUTRAS DOENÇAS (2)
erythrokeratodermia variabilis et progressiva 4erythrokeratodermia variabilis
HGNC:4021UniProt:Q06136

Medicamentos e terapias

IXEKIZUMABPhase 2

Mecanismo: Interleukin 17A inhibitor

GUSELKUMABPhase 2

Mecanismo: Interleukin-23 inhibitor

CRAVACITINIBPhase 2

Mecanismo: Tyrosine-protein kinase TYK2 negative allosteric modulator

DEUCRAVACITINIBPhase 2

Mecanismo: Tyrosine-protein kinase TYK2 negative allosteric modulator

SECUKINUMABPhase 1

Mecanismo: Interleukin 17A inhibitor

Ver mais no OpenTargets

Variantes genéticas (ClinVar)

152 variantes patogênicas registradas no ClinVar.

🧬 CARD14: NM_001366385.1(CARD14):c.357G>T (p.Met119Ile) ()
🧬 CARD14: NM_001366385.1(CARD14):c.1570del (p.Asp524fs) ()
🧬 CARD14: NM_001366385.1(CARD14):c.722C>T (p.Ser241Phe) ()
🧬 CARD14: NM_001366385.1(CARD14):c.1824dup (p.Arg610fs) ()
🧬 CARD14: NM_001366385.1(CARD14):c.*19G>A ()
Ver todas no ClinVar

Classificação de variantes (ClinVar)

Distribuição de 25 variantes classificadas pelo ClinVar.

19
6
Patogênica (76.0%)
VUS (24.0%)
VARIANTES MAIS SIGNIFICATIVAS
GJB3: NM_024009.3(GJB3):c.134G>A (p.Gly45Glu) [Likely pathogenic]
CERS3: NM_001378789.1(CERS3):c.1006C>T (p.Gln336Ter) [Likely pathogenic]
SDR9C7: NM_148897.3(SDR9C7):c.826C>T (p.Arg276Cys) [Pathogenic/Likely pathogenic]
ABCA12: NM_173076.3(ABCA12):c.3381_3481del (p.Ile1128fs) [Pathogenic]
KLK11: NM_001136032.3(KLK11):c.52G>A (p.Gly18Arg) [Pathogenic]

Diagnóstico

Os sinais que médicos procuram e os exames que confirmam

Carregando...

Tratamento e manejo

Remédios, cuidados de apoio e o que precisa acompanhar

Pipeline de tratamentos
Pipeline regulatório — de medicamentos já aprovados a drogas em pesquisa exploratória.
2Fase 24
1Fase 11
Medicamentos catalogadosEnsaios clínicos· 5 medicamentos · 0 ensaios
Carregando informações de tratamento...

Onde tratar no SUS

Hospitais de referência no Brasil e o protocolo oficial do SUS (PCDT)

🇧🇷 Atendimento SUS — Eritroceratodermia

🗺️

Selecione um estado ou use sua localização para ver resultados.

Dados de DATASUS/CNES, SBGM, ABNeuro e Ministério da Saúde. Sempre confirme a disponibilidade diretamente com o estabelecimento.

Pesquisa ativa

Ensaios clínicos abertos e novidades científicas recentes

Pesquisa e ensaios clínicos

Nenhum ensaio clínico registrado para esta condição.

🧪 Está conduzindo uma pesquisa?
Divulgue para pacientes e familiares que acompanham esta doença.
Divulgar pesquisa →

Publicações mais relevantes

Timeline de publicações
52 papers (10 anos)
#1

Progressive symmetrical erythrokeratoderma associated with biallelic PNPLA1 variants.

The British journal of dermatology2026 Mar 19
#2

A recurrent de novo damaging variant in EMP2 causes progressive symmetric erythrokeratoderma.

Proceedings of the National Academy of Sciences of the United States of America2025 Aug 12

Genetic investigation in Mendelian skin disorders featuring generalized or localized skin scaling and redness, known as the ichthyoses, has revealed novel pathways relevant to epidermal integrity, barrier function, and desquamation. Here, we show that a recurrent de novo missense variant in EMP2 (epithelial membrane protein 2), which encodes a cell surface tetraspan protein in the growth-arrest specific 3 (GAS3)/peripheral myelin protein 22 (PMP22) family, is associated with a Mendelian skin disorder in the progressive symmetric erythrokeratoderma spectrum. The disorder features severely thickened, red, and scaly skin at sites of wound healing or repetitive movement including on the face, genitals, flexural areas, and the palms and soles. EMP2 has previously been shown to directly associate with focal adhesion kinase, which links cell junction forces to signaling pathways relevant to proliferation, migration, and wound healing. Using single-cell spatial transcriptomics in affected tissue, we found ectopic suprabasal activation of signaling pathways downstream of receptor tyrosine kinases including epidermal growth factor receptor (EGFR), which we confirmed with western blotting in affected cells, supporting a gain-of-function mechanism for mutant EMP2. Remarkably, treatment with erlotinib, an EGFR inhibitor, led to marked clinical improvement underscoring the key role of EMP2 in epidermal differentiation and proliferation.

#3

Progressive Symmetric Erythrokeratoderma with Lesional Hypertrichosis: An Unusual Finding in a Rare Disease.

International journal of trichology2025

Progressive symmetric erythrokeratoderma (PSEK) is a rare genodermatosis with variable inheritance. It is characterized by symmetrical, erythematous, and hyperkeratotic plaques on the extremities. We report a case of a 16-year-old girl with PSEK of autosomal dominant inheritance associated with lesional hypertrichosis.

#4

Topical Treatments for Rare Genetic Dermatological Diseases: A Narrative Review.

Pharmaceuticals (Basel, Switzerland)2025 Nov 19

Rare diseases are conditions that affect up to 65 people per 100,000 individuals. They are also known as "orphan diseases", because they attract limited interest from researchers and pharmaceutical industries. Epidermolysis bullosa (EB), ichthyosis, Hailey-Hailey disease (HHD), Darier disease (DD), erythrokeratoderma, porokeratosis, inflammatory linear verrucous epidermal nevus (ILVEN) and piebaldism are examples of rare genetic skin diseases with few approved treatments. Topical treatments are the principal approach for rare dermatological diseases, and it can be useful to manage the symptoms or the patophysiology of these diseases. This study aimed to conduct a comprehensive review of the topical treatments of EB, ichthyosis, HHD, DD, erythrokeratodermias, porokeratosis, ILVEN, and piebaldism. The search was performed across the SciELO, MEDLINE®/PubMed®, Embase and Cochrane databases. This review identified porokeratosis, EB, and congenital ichthyosis as the rare genodermatoses with the highest number of reported studies and topical treatment options. In contrast, conditions such as piebaldism, erythrokeratodermia, and HHD have fewer reported topical interventions. For most rare genetic dermatological diseases, treatment aims to improve quality of life and control clinical signals and symptoms. Creams, gels, and ointments are frequently used as the main pharmaceutical approaches, and several pharmacological classes are employed, including keratolytics, retinoids, vitamin D analogs, topical corticosteroids, calcineurin inhibitors, and cytotoxic or antiproliferative agents. This review highlights the potential of off-label use of topical therapies as cost-effective alternatives in the treatment of rare genetic skin disorders. It also reinforces the critical role of compounded medicines in allowing for dose optimization, drug repurposing, and formulation adjustments, personalizing treatment to achieve improved therapeutic outcomes.

#5

Erythrokeratodermia-Cardiomyopathy Syndrome: Expanding the DSP Mutational Spectrum Beyond Proline Substitutions.

Pediatric dermatology2025 Oct 14

Erythrokeratodermia cardiomyopathy (EKC) syndrome is a rare autosomal dominant disorder characterized by generalized erythrokeratoderma and progressive dilated cardiomyopathy, caused by pathogenic variants in the SR6 domain of desmoplakin (DSP). We report two cases of EKC with novel de novo missense DSP variants at phenylalanine position 590 (F590S and F590V), expanding the mutational spectrum beyond proline substitutions. Immunostaining demonstrated disrupted desmosomal protein localization. One patient showed significant clinical improvement with ustekinumab therapy. These findings underscore the need for early cardiac monitoring and support IL-12/23p40 inhibition as a potential therapeutic strategy in EKC.

Publicações recentes

Ver todas no PubMed

📚 EuropePMC93 artigos no totalmostrando 52

2026

Progressive symmetrical erythrokeratoderma associated with biallelic PNPLA1 variants.

The British journal of dermatology
2025

Progressive Symmetric Erythrokeratoderma in an Adolescent With a Novel GJB3 Variant.

International journal of dermatology
2025

Progressive Symmetric Erythrokeratoderma with Lesional Hypertrichosis: An Unusual Finding in a Rare Disease.

International journal of trichology
2025

Topical Treatments for Rare Genetic Dermatological Diseases: A Narrative Review.

Pharmaceuticals (Basel, Switzerland)
2025

Erythrokeratodermia-Cardiomyopathy Syndrome: Expanding the DSP Mutational Spectrum Beyond Proline Substitutions.

Pediatric dermatology
2025

Effective Management of Familial Erythrokeratoderma Using Topical Calcipotriol.

Cureus
2025

A recurrent de novo damaging variant in EMP2 causes progressive symmetric erythrokeratoderma.

Proceedings of the National Academy of Sciences of the United States of America
2025

Expanding the SLURP1 disease spectrum: from Mal de Meleda to palmoplantar keratoderma/progressive symmetric erythrokeratoderma.

The British journal of dermatology
2025

Autosomal dominant SLURP1 variants cause palmoplantar keratoderma and progressive symmetric erythrokeratoderma.

The British journal of dermatology
2024

Four cases of Chanarin-Dorfman syndrome presenting with different types of erythrokeratoderma.

Pediatric dermatology
2024

Clinico-Epidemiologic Profile of Non-Syndromic Congenital Ichthyosis - A Retrospective Chart Review of 107 Patients.

Indian journal of dermatology
2024

Alitretinoin as a Treatment Modality for Ichthyosis in Women of Childbearing Age: A Case Series and Review of the Literature.

Dermatology (Basel, Switzerland)
2023

Integration of Phenotype Term Prioritization and Gene Expression Analysis Reveals a Novel Variant in the PERP Gene Associated with Autosomal Recessive Erythrokeratoderma.

Genes
2023

Oral Tofacitinib Therapy for the Effective Management of Netherton Syndrome.

Cureus
2024

Two New Families and a Literature Review of ELOVL4-Associated Spinocerebellar Ataxia Type 34.

Cerebellum (London, England)
2023

Variants in KLK11, affecting signal peptide cleavage of kallikrein-related peptidase 11, cause an autosomal-dominant cornification disorder.

The British journal of dermatology
2023

Variable skin findings in two siblings with KDSR mutations manifesting in PERIOPTER syndrome.

Pediatric dermatology
2021

Erythrokeratoderma variabilis (EKV) - First Nepalese case documenting GJB3 mutation.

Skin health and disease
2022

Diffuse plate-like sheets of desquamation.

JAAD case reports
2021

Analysis of TYR Gene Pathogenic Variants in a Chinese Mongolian Family with Progressive Symmetric Erythrokeratoderma.

Indian dermatology online journal
2022

Ichthyosis, psoriasiform dermatitis, and recurrent fungal infections in patients with biallelic mutations in PERP.

Journal of the European Academy of Dermatology and Venereology : JEADV
2021

Progressive hyperpigmented rash in a 10-year-old boy.

Pediatric dermatology
2022

Formation of keto-type ceramides in palmoplantar keratoderma based on biallelic KDSR mutations in patients.

Human molecular genetics
2022

Cardiac features in a patient with erythrokeratodermia cardiomyopathy syndrome.

Cardiology in the young
2021

Progressive symmetrical erythrokeratoderma manifesting as harlequin-like ichthyosis with severe thrombocytopenia secondary to a homozygous 3-ketodihydrosphingosine reductase mutation.

JAAD case reports
2021

ELOVL4 with erythrokeratoderma: A pediatric case and emerging genodermatosis.

American journal of medical genetics. Part A
2022

Dermoscopy of Erythrokeratoderma Variabilis.

Indian dermatology online journal
2020

Progressive Deformity of the Lower Limbs in a Patient with KID (Keratitis-Ichthyosis-Deafness) Syndrome.

Case reports in orthopedics
2020

Fulminant myocarditis following recurrent generalized erythrokeratoderma in a child with a heterozygous GJA1 variant.

American journal of medical genetics. Part A
2020

Clinical variability of the GJB4:c.35G > A gene variant: a study of a large Brazilian erythrokeratodermia pedigree.

International journal of dermatology
2020

Identification of a CDH12 potential candidate genetic variant for an autosomal dominant form of transgrediens and progrediens palmoplantar keratoderma in a Tunisian family.

Journal of human genetics
2020

Confirming the recessive inheritance of PERP-related erythrokeratoderma.

Clinical genetics
2019

Loricrin downregulation and epithelial-related disorders: a systematic review.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG
2019

Connexin 43 Mutations Lead to Increased Hemichannel Functionality in Skin Disease.

International journal of molecular sciences
2019

Progressive Symmetrical Erythrokeratoderma Associated with Punctate Palmoplantarkeratoderma.

Indian dermatology online journal
2019

Chronic symmetrically distributed hyperpigmented plaques in a middle-age woman.

JAAD case reports
2019

Mutations in PERP Cause Dominant and Recessive Keratoderma.

The Journal of investigative dermatology
2019

The PERIOPTER syndrome (periorificial and ptychotropic erythrokeratoderma): a new Mendelian disorder of cornification.

Journal of the European Academy of Dermatology and Venereology : JEADV
2018

Erythrokeratoderma: a manifestation associated with multiple types of ichthyoses with different gene defects.

The British journal of dermatology
2017

Biallelic Mutations in KDSR Disrupt Ceramide Synthesis and Result in a Spectrum of Keratinization Disorders Associated with Thrombocytopenia.

The Journal of investigative dermatology
2017

Keratitis-ichthyosis-deafness syndrome accompanied by disseminated cutaneous fungal infection.

The Journal of dermatology
2017

Mutations in KDSR Cause Recessive Progressive Symmetric Erythrokeratoderma.

American journal of human genetics
2017

Recessive progressive symmetric erythrokeratoderma results from a homozygous loss-of-function mutation of KRT83 and is allelic with dominant monilethrix.

Journal of medical genetics
2016

Late Onset Progressive Symmetric Erythrokeratoderma with Pseudo Ainhum.

Indian journal of dermatology
2016

Lethal Keratitis, Ichthyosis, and Deafness Syndrome Due to the A88V Connexin 26 Mutation.

Revista de investigacion clinica; organo del Hospital de Enfermedades de la Nutricion
2016

Progressive symmetrical erythrokeratoderma on the face: A rare condition and successful treatment with calcipotriol.

JAAD case reports
2016

Phenotype in a patient with p.D50N mutation in GJB2 gene resemble both KID and Clouston syndromes.

International journal of pediatric otorhinolaryngology
2016

Herpes simplex virus in erythrokeratoderma variabilis.

Dermatology online journal
2016

Erythrokeratoderma Variabilis Caused by p.Gly45Glu in Connexin 31: Importance of the First Extracellular Loop Glycine Residue for Gap Junction Function.

Acta dermato-venereologica
2016

Intrafamilial phenotypic heterogeneity of epidermolytic ichthyosis associated with a new missense mutation in keratin 10.

Clinical and experimental dermatology
2015

Progressive Symmetric Erythrokeratoderma Having Overlapping Features With Erythrokeratoderma Variabilis and Lesional Hypertrichosis: Is Nomenclature "Erythrokeratoderma Variabilis Progressiva" More Appropriate?

Indian journal of dermatology
2015

Phenotypic variability in gap junction syndromic skin disorders: experience from KID and Clouston syndromes' clinical diagnostics.

Journal of applied genetics
Ver todos os 93 no EuropePMC

Associações

Organizações que acompanham esta doença — pra ter apoio e orientação

Ainda não temos associações cadastradas para Eritroceratodermia.

É de uma associação que acompanha esta doença? Fale com a gente →

Comunidades

Grupos ativos de quem convive com esta doença aqui no Raras

Ainda não existe comunidade no Raras para Eritroceratodermia

Pacientes, familiares e cuidadores se organizam em comunidades pra compartilhar experiências, fazer perguntas e se apoiar. Você pode ser o primeiro.

Tire suas dúvidas

Perguntas, dicas e experiências compartilhadas aqui na página

Participe da discussão

Faça login para postar dúvidas, compartilhar experiências e interagir com especialistas.

Fazer login

Doenças relacionadas

Doenças com sintomas parecidos — ajudam quem ainda está buscando diagnóstico

Referências e fontes

Bases de dados externas citadas neste artigo

Publicações científicas

Artigos indexados no PubMed ligados a esta doença no grafo RarasNet — título, periódico e PMID direto da fonte, sem intermediação de IA.

  1. Progressive symmetrical erythrokeratoderma associated with biallelic PNPLA1 variants.
    The British journal of dermatology· 2026· PMID 41530952mais citado
  2. A recurrent de novo damaging variant in EMP2 causes progressive symmetric erythrokeratoderma.
    Proceedings of the National Academy of Sciences of the United States of America· 2025· PMID 40758889mais citado
  3. Progressive Symmetric Erythrokeratoderma with Lesional Hypertrichosis: An Unusual Finding in a Rare Disease.
    International journal of trichology· 2025· PMID 41346545mais citado
  4. Topical Treatments for Rare Genetic Dermatological Diseases: A Narrative Review.
    Pharmaceuticals (Basel, Switzerland)· 2025· PMID 41305004mais citado
  5. Erythrokeratodermia-Cardiomyopathy Syndrome: Expanding the DSP Mutational Spectrum Beyond Proline Substitutions.
    Pediatric dermatology· 2025· PMID 41088746mais citado
  6. Progressive Symmetric Erythrokeratoderma in an Adolescent With a Novel GJB3 Variant.
    Int J Dermatol· 2025· PMID 41366560recente

Bases de dados e fontes oficiais

Identificadores e referências canônicas usadas para montar este verbete.

  1. ORPHA:79355(Orphanet)
  2. MONDO:0019270(MONDO)
  3. GARD:18986(GARD (NIH))
  4. Variantes catalogadas(ClinVar)
  5. Busca completa no PubMed(PubMed)
  6. Q5396475(Wikidata)

Dados compilados pelo RarasNet a partir de fontes abertas (Orphanet, OMIM, MONDO, PubMed/EuropePMC, ClinicalTrials.gov, DATASUS, PCDT/MS). Este conteúdo é informativo e não substitui avaliação médica.

Conteúdo mantido por Agente Raras · Médicos e pesquisadores podem colaborar

Eritroceratodermia
Compêndio · Raras BR

Eritroceratodermia

ORPHA:79355 · MONDO:0019270
Medicamentos
5 registrados
MedGen
UMLS
C0432330
EuropePMC
Wikidata
Papers 10a
DiscussaoAtiva

Nenhuma novidade ainda. O agente esta monitorando.

0membros
0novidades